Selection of optimum conditions of biosynthesis of antibiotics of the wide range of action, active against multiresistant conditionally pathogenic infectious agent
71 48
Keywords:
аctinomycetes, antibiotics, cultural liquid, multiresistant test microorganisms, biomass, mycelium, antimicrobic activity,Abstract
Volumes of annually carried out chemical measures against locusts in the southeast of republic of Kazakhstan reach 120 000 hectares, at biological efficiency of insecticides from various groups of chemical compounds of 95,6-98,9 %. At the same time the death of useful entomofauna is observed. Application of a preparation form of an entomopathogenic fungi Beauveria bassiana (Bals)Vuill. in the form of oil suspension caused death of 71,0-97,5 % of the pest that is rather effective for control of locust number.References
1 Vincent J.L., Bihari D.J., Suter P.M. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA 1995; 274:639-44.
2 Weber D.J., Raasch R., Rutala W.A. Nosocomial infections in the ICU: the growing importance of antibiotic-resistant pathogens// Chest. – 1999.- V.115. – P.34-41.
3 Alberti C., Brun-Buisson C., Burchardi H. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study //Intensive Care Med. – 2002. – V. 28. – P.108-121.
4 Roder B.L., Nielson S.L., Mangussen P. Antibiotic usage in an intensive care unit in a Danish university hospital //J Antimicrob Chemother. – 1993. – V. 32. – Р.633-642.
5 Peralta G., Sanchez M.B., Garrido J.C. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia // J Antimicrob Chemother. – 2007. – V. – 60. – Р.855-63.
6 Dekhnich A., Ryabkova E., Kretchikova O. Antimicrobial resistance of nosocomial strains of Staphylococcus aureus in Russian ICUs: Results of multicenter study //Presented at 46th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2006), September 27-30, 2006, San Francisco, CA, USA.
7 Neuhauser M.M., Weinstein R.A., Rydman R. Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use //JAMA. – 2003. – V. 289. – № 7. – Р. 885-888.
8 Страчунский Л.С., Дехнич А.В., Эдельштейн И.А. Эпидемиология антибиотикорезистентности нозокомиальных штаммов Staphylococcus aureus в России: результаты многоцентрового исследования //Клин. Микробиология. Антимикроб. Химиотерапия.- 2002. – Т. 4. – № 4. – С. 325-336.
9 Bou G., Oliver A., Martinez-Beltran J. OXA-24, a novel class D B-lactmase with carbap-enemase activity in an Acinetobacter baumannii clinical strain // Antimicrob. Agents Chemother. – 2000. – V.44. – Р. 1556-1561.
10 Сидоренко С.В. Исследования распространения антибиотикорезистентности: практическое значение для медицины //
Инфекции и антимикробная терапия. – 2002. – V. 4. – № 2. – С.38-41.
11. Bradford P.A. Extended-Spectrum B-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat // Clinical microbiology reviews. –2001. – V. 14. – №. 4. – Р. 933-951.
12 Peralta G., Sanchez M.B., Garrido J.C. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia //J.Antimicrob Chemother. – 2007. – V. 60. – Р. 855-863.
13 Lodise T.P. Jr., Patel N., Kwa A. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection //Antimicrob Agents Chemother. – 2007. – V. 51. – P. 3510-35155.
14 Schwaber M.J., Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis //J Antimicrob Chemother. – 2007. – V. 60. – Р.913-920.
15 Brisse S., Milatovic D., Fluit A.C., Verhoef J., Schmitz F.J. Epidemiology of Quinolon resistance of Klebsiella pneumonia and
Klebsiella oxitoca in Europe // Eur. J. Clin. Microbial. Infect. Dis. – 2000. – V. 19. – Р. 64-68.
16 Яковлев С.В. Клиническое значение резистентности микроорганизмов для выбора режима антибактериальной терапии в хирургии // Consilium-medicum. 2001. Экстра-выпуск. – С. 11-14.
17 Ромашов О.М. Клиническое значение и антибиотикотерапия госпитальных инфекций, вызванных резистентными грамотрицательными микроорганизмами: автореферат дис. ... канд. мед. наук: – М., 2004. – 24 с.
2 Weber D.J., Raasch R., Rutala W.A. Nosocomial infections in the ICU: the growing importance of antibiotic-resistant pathogens// Chest. – 1999.- V.115. – P.34-41.
3 Alberti C., Brun-Buisson C., Burchardi H. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study //Intensive Care Med. – 2002. – V. 28. – P.108-121.
4 Roder B.L., Nielson S.L., Mangussen P. Antibiotic usage in an intensive care unit in a Danish university hospital //J Antimicrob Chemother. – 1993. – V. 32. – Р.633-642.
5 Peralta G., Sanchez M.B., Garrido J.C. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia // J Antimicrob Chemother. – 2007. – V. – 60. – Р.855-63.
6 Dekhnich A., Ryabkova E., Kretchikova O. Antimicrobial resistance of nosocomial strains of Staphylococcus aureus in Russian ICUs: Results of multicenter study //Presented at 46th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2006), September 27-30, 2006, San Francisco, CA, USA.
7 Neuhauser M.M., Weinstein R.A., Rydman R. Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use //JAMA. – 2003. – V. 289. – № 7. – Р. 885-888.
8 Страчунский Л.С., Дехнич А.В., Эдельштейн И.А. Эпидемиология антибиотикорезистентности нозокомиальных штаммов Staphylococcus aureus в России: результаты многоцентрового исследования //Клин. Микробиология. Антимикроб. Химиотерапия.- 2002. – Т. 4. – № 4. – С. 325-336.
9 Bou G., Oliver A., Martinez-Beltran J. OXA-24, a novel class D B-lactmase with carbap-enemase activity in an Acinetobacter baumannii clinical strain // Antimicrob. Agents Chemother. – 2000. – V.44. – Р. 1556-1561.
10 Сидоренко С.В. Исследования распространения антибиотикорезистентности: практическое значение для медицины //
Инфекции и антимикробная терапия. – 2002. – V. 4. – № 2. – С.38-41.
11. Bradford P.A. Extended-Spectrum B-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat // Clinical microbiology reviews. –2001. – V. 14. – №. 4. – Р. 933-951.
12 Peralta G., Sanchez M.B., Garrido J.C. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia //J.Antimicrob Chemother. – 2007. – V. 60. – Р. 855-863.
13 Lodise T.P. Jr., Patel N., Kwa A. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection //Antimicrob Agents Chemother. – 2007. – V. 51. – P. 3510-35155.
14 Schwaber M.J., Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis //J Antimicrob Chemother. – 2007. – V. 60. – Р.913-920.
15 Brisse S., Milatovic D., Fluit A.C., Verhoef J., Schmitz F.J. Epidemiology of Quinolon resistance of Klebsiella pneumonia and
Klebsiella oxitoca in Europe // Eur. J. Clin. Microbial. Infect. Dis. – 2000. – V. 19. – Р. 64-68.
16 Яковлев С.В. Клиническое значение резистентности микроорганизмов для выбора режима антибактериальной терапии в хирургии // Consilium-medicum. 2001. Экстра-выпуск. – С. 11-14.
17 Ромашов О.М. Клиническое значение и антибиотикотерапия госпитальных инфекций, вызванных резистентными грамотрицательными микроорганизмами: автореферат дис. ... канд. мед. наук: – М., 2004. – 24 с.
Downloads
How to Cite
Khassenova, A. K., Pichkhadze, G. M., Ultanbekova, G. D., Shakiev, S. S., Akilova, M. A., & Trenozhnikova, L. P. (2015). Selection of optimum conditions of biosynthesis of antibiotics of the wide range of action, active against multiresistant conditionally pathogenic infectious agent. Experimental Biology, 55(3), 142–147. Retrieved from https://bb.kaznu.kz/index.php/biology/article/view/292
Issue
Section
MICROBIOLOGY
